Thomas G. Bird
Impact in
- Hepatology top 0.5%
- Liver physiology and pathology
- Aging top 1%
- Genetics, Aging, and Longevity in Model Organisms
Papers in
- Hepatology 25
- Liver physiology and pathology 13
- Hepatocellular Carcinoma Treatment and Prognosis 10
- Liver Disease and Transplantation 4
- Co-authors
- Stuart J. ForbesLuke BoulterJohn P. IredaleOwen J. SansomRachel A. RidgwayDerek A. MannStefania LorenziniMiryam Müller
- Journals
- Journal of Hepatology (6 papers)Gut (5 papers)Nature Communications (4 papers)Journal of Clinical Oncology (4 papers)Value in Health (2 papers)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Thomas G. Bird
70 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Hepatology 1.3k
- Aging 181
- Physiology 762
- Immunology 598
- Epidemiology 910
Countries citing papers authored by Thomas G. Bird
This map shows the geographic impact of Thomas G. Bird's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas G. Bird with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas G. Bird more than expected).
Fields of papers citing papers by Thomas G. Bird
This network shows the impact of papers produced by Thomas G. Bird. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas G. Bird. The network helps show where Thomas G. Bird may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas G. Bird, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 3 | |
| 4 | Neutrophils as potential therapeutic targets in hepatocellular carcinoma Hit paper breakdown → | 2022 | 142 |
| 5 | 2022 | 3 | |
| 6 | 2022 | 4 | |
| 7 | 2021 | 3 | |
| 8 | 2021 | 33 | |
| 9 | 2020 | 22 | |
| 10 | 2019 | 6 | |
| 11 | Author Correction: Loss of BCL9/9l suppresses Wnt driven tumourigenesis in models that recapitulate human cancer (Nature Communications, (2019), 10, 1, (723), 10.1038/s41467-019-08586-3) | 2019 | 1 |
| 12 | 2019 | 98 | |
| 13 | 2019 | 61 | |
| 14 | 2016 | 23 | |
| 15 | 2016 | 28 | |
| 16 | Hepatic progenitor cells of biliary origin with liver repopulation capacity Hit paper breakdown → | 2015 | 345 |
| 17 | 2013 | 132 | |
| 18 | 2012 | 1 | |
| 19 | 1999 | 18 | |
| 20 | 1988 | 46 |
About Thomas G. Bird
Thomas G. Bird is a scholar working on Hepatology, Otorhinolaryngology, Epidemiology, Immunology and Insect Science, having authored 77 papers that have together received 3.7k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (18 papers), Liver physiology and pathology (13 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Pancreatic and Hepatic Oncology Research (5 papers), Esophageal Cancer Research and Treatment (5 papers), Pediatric Hepatobiliary Diseases and Treatments (4 papers), Insect and Pesticide Research (4 papers) and Liver Disease and Transplantation (4 papers). The work is most often cited by research in Hepatology (1.3k citations), Aging (181 citations), Physiology (762 citations), Immunology (598 citations) and Epidemiology (910 citations). Thomas G. Bird has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Stuart J. Forbes, Luke Boulter, John P. Iredale, Owen J. Sansom, Rachel A. Ridgway, Derek A. Mann, Stefania Lorenzini, Miryam Müller, Diana Jurk and João F. Passos. Their work appears in journals such as Journal of Hepatology, Gut, Nature Communications, Journal of Clinical Oncology and Value in Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.